Deborah Spak News
-
Two Chinese companies implicated in supplying contaminated ingredients three years ago to Baxter International Inc. for its blood thinner heparin are still supplying product to the U.S., Republican lawmakers said.
-
A jury said Teva Pharmaceutical Industries Ltd. and Baxter International Inc. must pay $90 million in punitive damages for selling reusable vials of the anesthetic Propofol that a colonoscopy patient blamed for his hepatitis.
-
Cerberus Capital Management LP reached a tentative settlement with Innkeepers USA Trust over claims that it breached an agreement to buy the hotel company, according to two people with knowledge of the discussions.
-
A jury said Teva Pharmaceutical Industries Ltd. unit and two other drugmakers must pay $162.5 million in punitive damages for selling the anesthetic Propofol in a way that led three colonoscopy patients to develop Hepatitis C.
-
A Teva Pharmaceutical Industries Ltd. unit and two other drugmakers were ordered by a jury to pay at least $20.1 million for selling the anesthetic Propofol in a way that led three colonoscopy patients to develop Hepatitis C.
-
Baxter International Inc. won a bid to force Teva Pharmaceutical Industries Ltd. to pay costs of defending Nevada lawsuits alleging that the drugmakers’ sales of the anesthetic propofol led to patients developing hepatitis.
-
A former executive at expert- networking firm Primary Global Research LLC, James Fleishman, was found guilty of helping pass confidential information to fund managers as part of an insider-trading scheme.
-
The liquidator of Bernard L. Madoff’s firm sued Lion Global Investors Ltd. and at least six other companies to recover at least $172.8 million they allegedly received from investments made with the con man by Fairfield Sentry Ltd.
-
Teva Pharmaceutical Industries Ltd., the world’s biggest generic-drug maker, sold the anesthetic propofol in a way that led some patients to develop hepatitis C, a lawyer said at the start of a second trial over the allegations.
-
Baxter International Inc ., a maker of intravenous drugs, was sued by a pension fund over allegedly misleading public statements made about the company’s business prospects.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page